中華民國癌症醫學會 TOS

Time Topic Speakers Moderator Meeting Room Abstract
10:00 - 10:10
Young Investigator Paper Award of TOS for Cancer Research 年輕研究者癌症研究傑出論文獎頒獎
Jen-Shi Chen
 701A
10:10 - 10:30
Young Investigator Award of TOS for Cancer Research 年輕研究者癌症研究傑出獎頒獎暨研究成果發表
Jen-Shi Chen
 701A
10:30 - 10:50
Young Investigator Award of TOS for Cancer Research 年輕研究者癌症研究傑出獎頒獎暨研究成果發表
Jen-Shi Chen
 701A
10:50 - 11:30
Chien-Tien Hsu’s Outstanding Cancer Research Award 徐千田癌症研究傑出獎頒獎暨專題演講
Jen-Shi Chen
 701A
11:30 - 12:30
會員大會 (腫瘤內科專科醫師授證、JCRP優秀論文獎頒獎-趙盈凱醫師、癌症醫學終身成就獎頒獎-王正旭醫師)
 701A
13:30 - 13:40
Opening Remarks
Jen-Shi Chen
 701A
13:40 - 14:20
JSCO/KSMO/TOS Joint Symposium
Refining the Role of Neoadjuvant Therapy in Gastrointestinal Cancers: Integration of ctDNA and Whole-Genome MRD Approaches
Yan-Shen Shan
 701A
14:20 - 15:00
JSCO/KSMO/TOS Joint Symposium
Balancing the Benefits and Risks of Adjuvant Therapy Across Different Cancer Types
Wen-Chi Chou
 701A
15:00 - 15:40
JSCO/KSMO/TOS Joint Symposium
Emerging Tools Such As ctDNA and MRD Monitoring Reshape the Integration of Neoadjuvant and Adjuvant Strategies Across Tumor Types
Li-Yuan Bai
 701A
15:40 - 15:50
Break
 701A
15:50 - 16:30
Exploring the Future of Extracellular Vesicle Research in Cancer Diagnosis and Therapy
Chiun Hsu
 701A
16:30 - 17:10
Spatial-powered AI Pathology H&E 2.0, Dark Proteome, AI-powered Pseudo-timeline for personalized medicine: Working toward Cancer Care 2030
Muh-Hwa Yang
 701A
17:10 - 17:20
Discussion & Closing
Jen-Shi Chen
 701A
Time Topic Speakers Moderator Meeting Room Abstract
09:00 - 09:35
Ta-Cheng Tung’s Basic Cancer Research Award 董大成博士癌症基礎醫學研究傑出獎頒獎暨專題演講
Jen-Shi Chen
 701A
09:35 - 10:10
Ta-Cheng Tung’s Basic Cancer Research Award 董大成博士癌症基礎醫學研究傑出獎頒獎暨專題演講
Jen-Shi Chen
 701A
10:10 - 10:20
Opening Remarks
Jen-Shi Chen
 701A
10:20 - 11:00
ESMO/JSMO/TOS Joint Symposium
ESMO/JSMO/TOS Joint Symposium: An Overview of Antibody–Drug Conjugates in Cancer Therapy
Yen Chia-Jui
 701A
11:00 - 11:10
Break
 701A
11:10 - 11:50
ESMO/JSMO/TOS Joint Symposium
Emerging Targets for Next-Generation Antibody-Drug Conjugate Development
Chao-Hua Chiu
 701A
11:50 - 12:30
ESMO/JSMO/TOS Joint Symposium
Mechanisms and Challenges of ADC Drug Resistance
Dah-Shyong Yu
 701A
12:30 - 12:40
Discussion & Closing
Jen-Shi Chen
 701A